Drug Overview
The drug with the National Drug Code (NDC) 00904-6948 is identified as Abiraterone Acetate 250 MG TAB. This medication is used primarily in the treatment of prostate cancer, particularly in patients with metastatic castration-resistant prostate cancer (mCRPC)[2].
Market Analysis
Global Market Overview
The global market for Abiraterone Acetate is part of the broader landscape of oncology treatments. The demand for this drug is driven by the increasing incidence of prostate cancer and the need for effective treatments. Pharmaceutical companies are focusing on therapy areas with high unmet needs, and oncology remains a key area of investment[3].
Competitive Landscape
The market for Abiraterone Acetate is competitive, with multiple vendors offering the drug. The NDC 00904-6948 is associated with several labelers, indicating a diverse market with various manufacturers and distributors. This competition can influence pricing strategies and market share[2].
Price Trends
Current Pricing
As of the latest data available, the price per unit for Abiraterone Acetate 250 MG TAB with the NDC 00904-6948 is approximately $1.07554 per unit as of December 18, 2024. This price is consistent across different labelers and vendors[2].
Historical Pricing
While specific historical price data for NDC 00904-6948 is not provided, the stability in pricing over recent months suggests a relatively stable market. However, prices can fluctuate based on various factors such as production costs, regulatory changes, and market demand.
Price Projections
Market Factors Influencing Price
Several factors can influence the future pricing of Abiraterone Acetate:
- Supply Chain Resilience: Pharmaceutical companies are investing in data, AI, and digital tools to optimize their supply chains. This could lead to more efficient production and potentially stable or reduced prices[3].
- Regulatory Changes: Proposed legislation and geopolitical changes can impact manufacturing and distribution costs, which may reflect in the pricing.
- Competitive Dynamics: The entry of new competitors or the launch of generic versions could drive prices down.
Using Advanced Projections Models
Companies like Komodo Health use advanced models that incorporate multiple datasets and statistical methods to provide accurate drug projections. These models can help predict market share, revenue forecasts, and pricing trends by analyzing real-time data and historical trends[4].
Evolving Pipeline and Launch Strategies
Pharmaceutical companies are evolving their pipeline and launch strategies to prioritize specific therapy areas and reduce costs. For instance, companies are focusing on novel modalities and mechanisms of action, which could impact the pricing and market dynamics of existing drugs like Abiraterone Acetate[3].
Impact of AI and Data on Drug Development
The increasing use of AI and data in drug development is expected to reduce costs and timelines. This could lead to more efficient production processes and potentially lower prices for drugs, including Abiraterone Acetate. For example, companies like Amgen and Sanofi are using AI to speed up clinical trials and patient recruitment, which can indirectly affect the pricing of drugs by reducing development costs[3].
Supply Chain Optimization
Pharmaceutical companies are optimizing their supply chains to build resilience and reduce costs. This includes investments in smart manufacturing and the use of AI to predict and manage supply chain disruptions. A more resilient supply chain can help maintain stable prices by reducing the risk of shortages and production delays[3].
Patient-Centric Trials and Inclusive Clinical Trials
The focus on patient-centric trials and making clinical trials more inclusive can also impact the long-term pricing of drugs. By speeding up recruitment and making trials more efficient, companies can reduce the overall cost of bringing a drug to market, which could reflect in more stable or lower prices[3].
Key Takeaways
- Stable Current Pricing: The current price per unit for Abiraterone Acetate 250 MG TAB with NDC 00904-6948 is around $1.07554.
- Competitive Market: The market is competitive with multiple vendors, which can influence pricing and market share.
- Supply Chain and AI: Investments in supply chain optimization and AI are expected to reduce costs and improve efficiency, potentially stabilizing or reducing prices.
- Evolving Pipeline Strategies: Pharmaceutical companies are focusing on novel modalities and high unmet needs areas, which could impact the market dynamics of existing drugs.
Frequently Asked Questions (FAQs)
Q: What is the primary use of Abiraterone Acetate 250 MG TAB?
A: Abiraterone Acetate 250 MG TAB is primarily used in the treatment of prostate cancer, particularly in patients with metastatic castration-resistant prostate cancer (mCRPC).
Q: How does the competitive landscape affect the pricing of Abiraterone Acetate?
A: The competitive landscape, with multiple vendors offering the drug, can drive pricing strategies and influence market share. Competition can lead to stable or reduced prices.
Q: What role does AI play in the pricing of pharmaceutical drugs?
A: AI helps in optimizing supply chains, reducing drug development costs and timelines, and making clinical trials more efficient. These efficiencies can indirectly affect pricing by reducing overall costs.
Q: How do regulatory changes impact the pricing of Abiraterone Acetate?
A: Regulatory changes can affect manufacturing and distribution costs, which may reflect in the pricing. Proposed legislation and geopolitical changes are key factors to consider.
Q: What advanced models are used for drug price projections?
A: Advanced models like those from Komodo Health use multiple datasets and statistical methods to provide accurate drug projections, helping predict market share, revenue forecasts, and pricing trends.
Cited Sources
- Drug Patent Watch - Latest pharmaceutical drug prices and trends for NDC 00904-5448
- Drug Patent Watch - Pharmaceutical drug prices and trends for ABIRATERONE ACETATE
- ZS - Exploring 2025 pharma industry trends, outlook and strategies
- Komodo Health - Drug Projections
- FDA - National Drug Code Directory
